Abivax completes pre-NDA meeting with FDA for ulcerative colitis drug

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/18/2026

1. SPY
2. FLNC
3. CRM
4. GNRC
5. CRWV
6. NVDA
7. LEN
8. USO
9. LMT
10. TLT

Go back to Abivax completes pre-NDA meeting with FDA for ulcerative colitis drug
(NASDAQ: ABVX) Delayed: 106.99 --0 (-0%)
Previous Close $106.99    52 Week High $ 
Open $104.59    52 Week Low $ 
Day High $107.60    P/E N/A 
Day Low $104.15    EPS $ 
Volume 1,732